ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Calle, Roberto A., Amin, Neeta B., Carvajal-Gonzalez, Santos · Nature Medicine · 2021